Peptide performance claims: what Brian Shaw-style content gets wrong

What's this video probably claiming?

Based on the caption, hashtags, and the peptide content category, this video is likely making the case that peptide therapy, whether BPC-157, TB-500, CJC-1295, ipamorelin, or some combination, delivers the kind of "absolutely insane" performance and physique results associated with elite strength athletes like four-time World's Strongest Man Brian Shaw. The framing of Shaw as a reference point is doing a lot of work here. It implies a causal connection between peptide use and elite-level physicality, a connection that is, at best, wildly overclaimed. Videos in this category routinely suggest that peptides accelerate recovery, spike growth hormone, and produce muscle hypertrophy at a rate that normal training cannot match. The underlying message: if you want to look and perform like a professional strongman, peptides are the lever you should be pulling.

What does the science actually show?

The honest answer is: much less than gym TikTok wants you to believe. BPC-157 has shown accelerating effects on tendon and muscle repair in rodent models, with Sikiric et al. (2018, Current Pharmaceutical Design) documenting improved healing in gastrocnemius muscle tears in rats at doses of 10 mcg/kg. TB-500, a synthetic fragment of Thymosin Beta-4, has similarly promising preclinical data, but zero randomized controlled trials in healthy humans for performance enhancement. CJC-1295 combined with ipamorelin does produce measurable increases in IGF-1 and growth hormone pulse amplitude. A Teichman et al. (2006, Journal of Clinical Endocrinology and Metabolism) trial showed IGF-1 increases of roughly 30-40% over baseline with CJC-1295 in adults, but subjects were not athletes, doses were tightly controlled, and the study was not designed to measure physique outcomes. The jump from "raises IGF-1" to "builds muscle like a strongman" is not supported by the existing literature.

Where does the social media noise diverge from clinical reality?

Several places. First, nearly all the compelling peptide data comes from animal studies or small, short-duration human trials in clinical populations, not healthy trained athletes. Extrapolating rodent tendon healing to human muscle hypertrophy is a methodological leap that peer reviewers would reject immediately. Second, the peptides discussed in this content category are largely unscheduled research chemicals in the United States, not FDA-approved drugs. Compounded versions vary substantially in purity and actual peptide content, a problem documented by Cohen et al. (2022, JAMA Internal Medicine) who found significant labeling inaccuracies in compounded peptide products. Third, citing a professional strongman as implicit evidence of peptide efficacy ignores the enormous role of genetics, decades of progressive training, elite nutrition, and, candidly, other pharmacological agents that are far more potent than any peptide on this list.

What should you actually know?

Peptides are not magic, and they are not nothing. Some, like GHK-Cu for skin repair, have a reasonably solid mechanistic basis for specific, limited applications. Others, like semax and selank, are being investigated for cognitive and anxiolytic effects with preliminary but not conclusive data. The category is genuinely interesting from a research standpoint. What it is not, right now, is a clinically validated performance enhancement system for healthy athletes chasing strongman-level results. If you are considering peptide therapy for a legitimate purpose, such as recovery support after injury, that is a conversation worth having with a licensed provider who can review your health history. Self-administering injectable research peptides sourced from unverified online suppliers because a TikTok caption said "absolutely insane" is not a medical strategy. It is a risk profile. The regulatory, safety, and efficacy questions here are real, and they are not resolved by a motivational hashtag.